The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Open accessAbstract
Major depressive disorder (MDD), also referred to as depression, is one of the most common psychiatric disorders with a high economic burden. The etiology of depression is still not clear, but it is generally believed that MDD is a multifactorial disease caused by the interaction of social, psychological, and biological aspects. Therefore, there is no exact pathological theory that can independently explain its pathogenesis, involving genetics, neurobiology, and neuroimaging. At present, there are many treatment measures for patients with depression, including drug therapy, psychotherapy, and neuromodulation technology. In recent years, great progress has been made in the development of new antidepressants, some of which have been applied in the clinic. This article mainly reviews the research progress, pathogenesis, and treatment of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 2×
“cytokine inducers, while antidepressants relieve these symptoms [55, 56].”
BackgroundeQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0326-7 · Cited by 2,565 · cited 1×
“A recent GWAS of 807,553 individuals with depression reported that 102 independent variants were associated with depression; these were involved in synaptic structure and neural transmission, and were verified in a further 1,507,153 individuals [100].”
BackgroundGut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“The potential mechanism may be that gut microbiota can interact with the brain through a variety of pathways or systems, including the HPA axis, and the neuroendocrine, autonomic, and neuroimmune systems [81].”
BackgroundPrevalence of mental disorders in China: a cross-sectional epidemiological study
Huang, Y., Wang, Y., Wang, H., Liu, Z., Yu, X., Yan, J., Yu, Y., Kou, C., Xu, X., Lu, J., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30511-x · Cited by 2,335
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 2×
“Interestingly, some evidence indicates that rodents exhibit depressive behavior after fecal transplants from patients with depression [74].”
BackgroundSelf-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009 · cited 1×
“About 40%–60% of patients with depression display a disturbed HPA axis, including hypercortisolemia, decreased rhythmicity, and elevated cortisol levels [16, 17].”
BackgroundPrevalence of Depression in the Community from 30 Countries between 1994 and 2014
Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21243-x · Cited by 1,557
for the ENIGMA-Major Depressive Disorder Working Group, Schmaal, L., Hibar, D. P., Sämann, P. G., Hall, G. B., Baune, B. T., Jahanshad, N., Cheung, J. W., van Erp, T. G. M., Bos, D., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.60 · Cited by 1,330
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
for the ENIGMA-Major Depressive Disorder Working Group, Schmaal, L., Veltman, D. J., van Erp, T. G. M., Sämann, P. G., Frodl, T., Jahanshad, N., Loehrer, E., Tiemeier, H., Hofman, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.69 · Cited by 1,172 · cited 1×
“Medicine type Samples Methods Region Method of analysis Main outcomes Schmaal et al. 2016 [142] 1,728 MDD patients and 7,199 controls sMRI Subcortical volumes Meta- analysis Hippocampal volume was lower in MDD than controls.”
MethodStetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123 · cited 1×
“unfortunately previous studies have shown that treatments regulating the HPA axis, such as glucocorticoid receptor antagonists, do not attenuate the symptoms of depressed patients [24, 25].”
BackgroundA mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116 · cited 1×
“It is well established that comorbidity of depression and gastrointestinal diseases is common [70, 71].”
BackgroundO'Mahony, S. M., Marchesi, J. R., Scully, P., Codling, C., Ceolho, A.-M., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.026 · Cited by 1,069 · cited 1×
“Early animal studies have shown that stress can lead to long-term changes in the diversity and composition of intestinal microflora, and is accompanied by depressive behavior [76, 77].”
BackgroundAndrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
Study, L. C., Okbay, A., Baselmans, B. M. L., De Neve, J.-E., Turley, P., Nivard, M. G., Fontana, M. A., Meddens, S. F. W., Linnér, R. K., Rietveld, C. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3552 · Cited by 1,013 · cited 8×
“Further, some evidence also showed an asso- ciation between brain network dysfunction and the clinical correlates of patients with depression, including clinical symptoms [117] and the response to antidepressants [118, 119], ECT [120, 121], and repetitive transcranial magnetic stimulation [122].”
BackgroundMethodInfluentialKeller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922
Popova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19020172 · Cited by 904
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
The Genetics of Major Depression
Flint, J., & Kendler, K. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.027 · Cited by 724
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16cs10905 · Cited by 693 · cited 1×
“meta-analysis studies has shown that rTMS can treat depressive patients with safety [154].”
BackgroundLamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Psychiatric Genomics: An Update and an Agenda
Sullivan, P. F., Agrawal, A., Bulik, C. M., Andreassen, O. A., Børglum, A. D., Breen, G., Cichon, S., Edenberg, H. J., Faraone, S. V., Gelernter, J., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030283 · Cited by 676
Precision psychiatry: a neural circuit taxonomy for depression and anxiety
Williams, L. M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00579-9 · Cited by 641
Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis
Mittal, R., Debs, L. H., Patel, A. P., Nguyen, D., Patel, K., O'Connor, G., Grati, M., Mittal, J., Yan, D., Eshraghi, A. A., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25518 · Cited by 636
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
Messaoudi, M., Violle, N., Bisson, J.-F., Desor, D., Javelot, H., & Rougeot, C. (2011) · Gut Microbes · doi:10.4161/gmic.2.4.16108 · Cited by 574 · cited 1×
“studies, [78] and had antidepressant effects on patients with depression in several double-blind, placebo-controlled clinical trials [79, 80].”
BackgroundInflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
Rudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499
Depression, Neuroimaging and Connectomics: A Selective Overview
Gong, Q., & He, Y. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.009 · Cited by 496
Feeding the microbiota–gut–brain axis: Diet, microbiome, and neuropsychiatry
Sandhu, K. V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017) · Translational Research · doi:10.1016/j.trsl.2016.10.002 · Cited by 491
Targeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482 · cited 1×
“To date, although several potential drugs have not yet been approved by the FDA, they are key milestones in the development of antidepressants that may be modified and used clinically in the future, such as compounds containing dextromethorphan (a non-selective NMDAR antago–nist), sarcosine (N-methylglycine, a glycine…”
BackgroundOxidative stress, inflammation and treatment response in major depression
Lindqvist, D., Dhabhar, F. S., James, S. J., Hough, C. M., Jain, F. A., Bersani, F. S., Reus, V. I., Verhoeven, J. E., Epel, E. S., Mahan, L., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.031 · Cited by 473 · cited 2×
“interaction between the HPA and mitochondrial metabolism [89, 90], and the reciprocal interaction between oxidative stress and inflammation [2, 85]).”
BackgroundLener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468 · cited 1×
“It has been suggested that a functional imbalance of the GABA and glutamate systems contributes to the pathophysiology of depression, and activation of the GABA system might induce antidepressant activity, by which GABAA receptor mediators a2/a3 are considered potential antidepressant candidates [42, 43].”
BackgroundDepression in the Primary Care Setting
Park, L. T., & Zarate, C. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1712493 · Cited by 458
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449
Dadi, A. F., Miller, E. R., Bisetegn, T. A., & Mwanri, L. (2020) · BMC Public Health · doi:10.1186/s12889-020-8293-9 · Cited by 421
Sullivan, P. F., de Geus, E. J. C., Willemsen, G., James, M. R., Smit, J. H., Zandbelt, T., Arolt, V, Baune, B. T., Blackwood, D., Cichon, S., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.125 · Cited by 404
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378 · cited 1×
“decreased levels of the GABA synthase glutamic acid decarboxylase in the prefrontal cortex of patients with depression [40, 41].”
BackgroundMicrobiota alteration is associated with the development of stress-induced despair behavior
Marin, I. A., Goertz, J. E., Ren, T., Rich, S. S., Onengut-Gumuscu, S., Farber, E., Wu, M., Overall, C. C., Kipnis, J., & Gaultier, A. (2017) · Scientific Reports · doi:10.1038/srep43859 · Cited by 369
Duman, R. S., & Li, N. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0357 · Cited by 362
Boldrini, M., Santiago, A. N., Hen, R., Dwork, A. J., Rosoklija, G. B., Tamir, H., Arango, V., & John Mann, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.5 · Cited by 361
van Velzen, L. S., Kelly, S., Isaev, D., Aleman, A., Aftanas, L. I., Bauer, J., Baune, B. T., Brak, I. V., Carballedo, A., Connolly, C. G., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0477-2 · Cited by 356
Schür, R. R., Draisma, L. W. R., Wijnen, J. P., Boks, M. P., Koevoets, M. G. J. C., Joëls, M., Klomp, D. W., Kahn, R. S., & Vinkers, C. H. (2016) · Human Brain Mapping · doi:10.1002/hbm.23244 · Cited by 349
Greden, J. F., Parikh, S. V., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Mondimore, F. M., Shelton, R. C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.003 · Cited by 347 · cited 1×
“conducted an 8-week RCT of Genomics Used to Improve Depression Decisions (GUIDED) on 1,167 MDD patients and demonstrated that although there was no difference in symptom improvement between the pharmacogenomics-guided and non- pharmacogenomics-guided groups, the response rate and remission rate of the pharmacogenomics…”
MethodHan, L. K. M., Dinga, R., Hahn, T., Ching, C. R. K., Eyler, L. T., Aftanas, L., Aghajani, M., Aleman, A., Baune, B. T., Berger, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0754-0 · Cited by 334
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Kennedy, P. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14105 · Cited by 331
Fee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Brakowski, J., Spinelli, S., Dörig, N., Bosch, O. G., Manoliu, A., Holtforth, M. G., & Seifritz, E. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.04.007 · Cited by 328
Joshi, S. H., Espinoza, R. T., Pirnia, T., Shi, J., Wang, Y., Ayers, B., Leaver, A., Woods, R. P., & Narr, K. L. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.029 · Cited by 320
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
Altered Brain Activity in Unipolar Depression Revisited: Meta-analyses of Neuroimaging Studies
Müller, V. I., Cieslik, E. C., Serbanescu, I., Laird, A. R., Fox, P. T., & Eickhoff, S. B. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2783 · Cited by 304
Williams, L. M. (2017) · Depression and Anxiety · doi:10.1002/da.22556 · Cited by 291
Haroon, E., Daguanno, A. W., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Wommack, E. C., Felger, J. C., & Miller, A. H. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.026 · Cited by 291
Chase, H. W., Boudewyn, M. A., Carter, C. S., & Phillips, M. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0499-9 · Cited by 286 · cited 1×
“treatments for depression have emerged, such as transcranial direct current stimulation (tDCS) [155], transcranial alternating current stimulation (tACS)[156], vagal nerve stimulation [157], deep brain stimulation [158] , and light therapy [159], but some of them are still experimental to some extent and have not been…”
BackgroundSwitching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder
Zhang, L., Zhang, J., & You, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00306 · Cited by 280
Qaseem, A., Barry, M. J., Kansagara, D., & for the Clinical Guidelines Committee of the American College of Physicians (2016) · Annals of Internal Medicine · doi:10.7326/m15-2570 · Cited by 279
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265 · cited 1×
“especially in melancholic depression [20, 21].”
The ERK Pathway: Molecular Mechanisms and Treatment of Depression
Wang, J. Q., & Mao, L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1524-3 · Cited by 263
Sex differences in glutamate receptor gene expression in major depression and suicide
Gray, A. L., Hyde, T. M., Deep-Soboslay, A., Kleinman, J. E., & Sodhi, M. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.91 · Cited by 250
Schmaal, L., Pozzi, E., C. Ho, T., van Velzen, L. S., Veer, I. M., Opel, N., Van Someren, E. J. W., Han, L. K. M., Aftanas, L., Aleman, A., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0842-6 · Cited by 245
Pearson Murphy, B. E. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90312-s · Cited by 244
Hao, Z., Wang, W., Guo, R., & Liu, H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.025 · Cited by 242 · cited 1×
“studies, [78] and had antidepressant effects on patients with depression in several double-blind, placebo-controlled clinical trials [79, 80].”
BackgroundAlexander, M. L., Alagapan, S., Lugo, C. E., Mellin, J. M., Lustenberger, C., Rubinow, D. R., & Fröhlich, F. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0439-0 · Cited by 224
Bradley, P., Shiekh, M., Mehra, V., Vrbicky, K., Layle, S., Olson, M. C., Maciel, A., Cullors, A., Garces, J. A., & Lukowiak, A. A. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.024 · Cited by 222
Albert, P. R., Benkelfat, C., & Descarries, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0190 · Cited by 218
Syed, S. A., Beurel, E., Loewenstein, D. A., Lowell, J. A., Craighead, W. E., Dunlop, B. W., Mayberg, H. S., Dhabhar, F., Dietrich, W. D., Keane, R. W., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.001 · Cited by 211
Schmaal, L., Veltman, D. J., van Erp, T. G. M., Sämann, P. G., Frodl, T., Jahanshad, N., Loehrer, E. A., Tiemeier, H. W., Albert Hofman, D., Niessen, W. J., et al. (2015) · QUT ePrints (Queensland University of Technology) · Cited by 207
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C. A., Feyissa, A. M., & Rajkowska, G. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990587 · Cited by 203
Ghosal, S., Hare, B. D., & Duman, R. S. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.09.012 · Cited by 199
Williams, L. M., Korgaonkar, M. S., Song, Y. C., Paton, R., Eagles, S., Goldstein-Piekarski, A., Grieve, S. M., Harris, A. W. F., Usherwood, T., & Etkin, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.89 · Cited by 195
Correia-Melo, F. S., Leal, G. C., Vieira, F., Jesus-Nunes, A. P., Mello, R. P., Magnavita, G., Caliman-Fontes, A. T., Echegaray, M. V. F., Bandeira, I. D., Silva, S. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.086 · Cited by 193
Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S.-C., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy008 · Cited by 183 · cited 1×
“In addition, mounting studies have reported that the BDNF level is decreased in the peripheral blood and at post-mortem in depressive patients, and some have reported that antidepressant treatment normalizes it [51, 52].”
Epigenetic mechanisms of major depression: Targeting neuronal plasticity
Uchida, S., Yamagata, H., Seki, T., & Watanabe, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12621 · Cited by 181 · cited 1×
“These new mechanisms of trans-generational transmission of epigenetic markers are considered a supplement to orthodox genetic heredity, providing the possibility for the discovery of new treatments for depression [102, 103].”
BackgroundPapakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180 · cited 2×
“However, the development of reliable diagnosis for MDD using biomarkers is still difficult and elusive, and all methods based on a single marker are insufficiently specific and sensitive for clinical use [142].”
BackgroundMethodConnolly, C. G., Ho, T. C., Blom, E. H., LeWinn, K. Z., Sacchet, M. D., Tymofiyeva, O., Simmons, A. N., & Yang, T. T. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.026 · Cited by 177
Musazzi, L., Treccani, G., Mallei, A., & Popoli, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.009 · Cited by 172
The role of glutamate on the action of antidepressants
Hashimoto, K. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.013 · Cited by 170
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Kadriu, B., Musazzi, L., Henter, I. D., Graves, M., Popoli, M., & Zarate, C. A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy094 · Cited by 165
Do your gut microbes affect your brain dopamine?
González‐Arancibia, C., Urrutia-Piñones, J., Illanes-González, J., Martínez-Pinto, J., Sotomayor‐Zárate, R., Julio‐Pieper, M., & Bravo, J. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05265-5 · Cited by 163
Kiecolt-Glaser, J. K., Wilson, S. J., Bailey, M. L., Andridge, R., Peng, J., Jaremka, L. M., Fagundes, C. P., Malarkey, W. B., Laskowski, B., & Belury, M. A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.007 · Cited by 160
Levinson, D. F., Mostafavi, S., Milaneschi, Y., Rivera, M., Ripke, S., Wray, N. R., & Sullivan, P. F. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.029 · Cited by 159
Genetic Determinants of Depression: Recent Findings and Future Directions
Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000054 · Cited by 158
Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval
Turner, E. H. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30394-3 · Cited by 156
Chandley, M., Szebeni, A., Szebeni, K., Crawford, J. D., Stockmeier, C. A., Turecki, G., Kostrzewa, R. M., & Ordway, G. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000662 · Cited by 155
Effect of psychotherapy for depression on quality of life: meta-analysis
Kolovos, S., Kleiboer, A., & Cuijpers, P. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.175059 · Cited by 153 · cited 2×
“2017 [143] 2,148 MDD patients and 7,957 healthy controls sMRI Cortical thickness and surface region Metaanalysis Gray matter of orbital prefrontal lobe, anterior cingulate gyrus, posterior cingulate gyrus, insular lobe, and temporal lobe in adult MDD patients was thinner than that in the control group.”
Backgroundvan Eijndhoven, P., van Wingen, G. A., Katzenbauer, M., Groen, W. B., Tepest, R., Fernández, G., Buitelaar, J. K., & Tendolkar, I. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12121504 · Cited by 139
Geerlings, M. I., & Gerritsen, L. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.032 · Cited by 138
Peng, W., Chen, Z., Yin, L., Jia, Z., & Gong, Q. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.001 · Cited by 136
Long, Z., Du, L., Zhao, J., Wu, S., Zheng, Q., & Lei, X. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.072 · Cited by 136
Inflammation-induced depression: Its pathophysiology and therapeutic implications
Jeon, S. W., & Kim, Y.-K. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.016 · Cited by 134
The genetics of depression: successful genome-wide association studies introduce new challenges
Ormel, J., Hartman, C. A., & Snieder, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0450-5 · Cited by 130
The neuropsychological profile of psychotic major depression and its relation to cortisol
Gomez, R. G., Fleming, S. H., Keller, J., Flores, B., Kenna, H., DeBattista, C., Solvason, B., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.010 · Cited by 127
Rentería, M. E., Schmaal, L., Hibar, D. P., Couvy‐Duchesne, B., Strike, L. T., Mills, N. T., de Zubicaray, G. I., McMahon, K. L., Medland, S. E., Gillespie, N. A., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.84 · Cited by 121
Yeshurun, S., & Hannan, A. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0039-z · Cited by 121
Depression and peripheral inflammatory profile of patients with obesity
Ambrósio, G., Kaufmann, F. N., Manosso, L. M., Platt, N., Ghisleni, G., Rodrigues, A. L. S., Rieger, D. K., & Kaster, M. P. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.005 · Cited by 119
Childhood adversity impacts on brain subcortical structures relevant to depression
Frodl, T., Janowitz, D., Schmaal, L., Tozzi, L., Dobrowolny, H., Stein, D. J., Veltman, D. J., Wittfeld, K., van Erp, T. G. M., Jahanshad, N., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.11.010 · Cited by 117
Gould, T. D., O’Donnell, K. C., Dow, E. R., Du, J., Chen, G., & Manji, H. K. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.002 · Cited by 114
García‐Ródenas, C. L., Bergonzelli, G. E., Nutten, S., Schumann, A., Cherbut, C., Turini, M., Ornstein, K., Rochat, F., & Corthésy‐Theulaz, I. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226376.95623.9f · Cited by 114
Ren, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.009 · Cited by 114
Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex
Godlewska, B. R., Browning, M. D., Norbury, R., Igoumenou, A., Cowen, P. J., & Harmer, C. J. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy069 · Cited by 113
Goldstein-Piekarski, A. N., Staveland, B. R., Ball, T. M., Yesavage, J., Korgaonkar, M. S., & Williams, L. M. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0100-3 · Cited by 108
Zheng, W., Cai, D.-B., Xiang, Y.-Q., Jiang, W., Sim, K., Ungvari, G. S., Huang, X., Huang, X.-X., Ning, Y., & Xiang, Y.-T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.002 · Cited by 107
Tozzi, L., Garczarek, L., Janowitz, D., Stein, D. J., Wittfeld, K., Dobrowolny, H., Lagopoulos, J., Hatton, S. N., Hickie, I. B., Carballedo, A., et al. (2019) · Psychological Medicine · doi:10.1017/s003329171900093x · Cited by 104
Kessler, R. C. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000377 · Cited by 103
Du, L., Liu, H., Du, W., Chao, F., Zhang, L., Wang, K., Huang, C., Gao, Y., & Tang, Y. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0005-6 · Cited by 103
Gryglewski, G., Baldinger, P., Seiger, R., Godbersen, G. M., Michenthaler, P., Klöbl, M., Spurny‐Dworak, B., Kautzky, A., Vanicek, T., Kasper, S. F., et al. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.224 · Cited by 101
A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression
Zhou, C., Zhang, H., Qin, Y., Tian, T., Xu, B., Chen, J., Zhou, X., Zeng, L., Fang, L., Qi, X., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.012 · Cited by 100
Self-citationUS Food and Drug Administration approval of esketamine and brexanolone
Cristea, I. A., & Naudet, F. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30292-5 · Cited by 98
Fabbri, C., Hosák, L., Mößner, R., Giegling, I., Mandelli, L., Bellivier, F., Claes, S. J., Collier, D. A., Corrales, A., DeLisi, L. E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1208843 · Cited by 92
Maller, J. J., Broadhouse, K., Rush, A. J., Gordon, E., Koslow, S., & Grieve, S. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.224 · Cited by 87
Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
Innes, S. C., Pariante, C. M., & Borsini, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.233 · Cited by 82
The Genetics of Major Depression
Flint, J., & Kendler, K. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.033 · Cited by 81
Chen, G., Guo, Y., Zhu, H., Kuang, W., Bi, F., Ai, H., Gu, Z., Huang, X., Lui, S., & Gong, Q. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.011 · Cited by 81
Dodd, S., Mitchell, P. B., Bauer, M., Yatham, L. N., Young, A. H., Kennedy, S. H., Williams, L. J., Suppes, T. M., López‐Jaramillo, C., Trivedi, M. H., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1379609 · Cited by 77
Xie, X., Shen, Q., Yu, C., Xiao, Q., Zhou, J., Xiong, Z., Li, Z., & Fu, Z. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105607 · Cited by 77
Self-citationBeurel, E., Grieco, S. F., Amadei, C., Downey, K., & Jope, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12436 · Cited by 76
Akhtar, H., Bukhari, F., Nazir, M., Anwar, M. N., & Shahzad, A. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-015-0009-2 · Cited by 74
de Kovel, C. G. F., Aftanas, L. I., Aleman, A., Alexander‐Bloch, A. F., Baune, B. T., Brack, I., Bülow, R., Busatto, G. F., Carballedo, A., Connolly, C. G., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101144 · Cited by 74
Li, Z., Zhang, C., Fan, J., Yuan, C., Huang, J., Chen, J., Yi, Z., Wang, Z., Hong, W., Wang, Y., et al. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134064 · Cited by 73
Self-citationWang, F., Zhang, Q.-E., Zhang, L., Ng, C. H., Ungvari, G. S., Yuan, Z., Zhang, J., Zhang, L., & Xiang, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.061 · Cited by 72
Li, K., Shen, S., Ji, Y., Li, X., Zhang, L., & Wang, X. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0189-z · Cited by 70
Li, Z., Qi, D., Chen, J., Zhang, C., Yi, Z., Yuan, C., Wang, Z., Hong, W., Yu, S., Cui, D., et al. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.05.005 · Cited by 69
Self-citationShekelle, P., Cook, I. A., Miake-Lye, I. M., Booth, M. S., Beroes, J. M., & Mak, S. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1970 · Cited by 69
Mao, R., Zhang, C., Chen, J., Zhao, G., Zhou, R., Wang, F., Xu, J., Yang, T., Su, Y., Huang, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.115 · Cited by 68
Self-citationXie, X., Yu, C., Zhou, J., Xiao, Q., Shen, Q., Xiong, Z., Li, Z., & Fu, Z. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.147 · Cited by 67
Self-citationDiviccaro, S., Giatti, S., Borgo, F., Barcella, M., Borghi, E., Trejo, J. L., García‐Segura, L. M., & Melcangi, R. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.021 · Cited by 66
Leaver, A. M., Vasavada, M. M., Joshi, S. H., Wade, B., Woods, R. P., Espinoza, R. T., & Narr, K. L. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.021 · Cited by 66
Gill, S. P., & Kellner, C. H. (2019) · The Journal of ECT · doi:10.1097/yct.0000000000000484 · Cited by 65
Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
Zhu, S., Zhao, L., Fan, Y., Lv, Q., Wu, K., Lang, X., Li, Z., Yi, Z., & Geng, D. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104595 · Cited by 64
Self-citationLi, Z., Zhang, Y., Wang, Z., Chen, J., Fan, J., Guan, Y., Zhang, C., Yuan, C., Hong, W., Wang, Y., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.003 · Cited by 63
Self-citationLiu, J., Yan, F., Ma, X., Guo, H.-L., Tang, Y., Rakofsky, J. J., Wu, X., Li, X., Zhu, H., Guo, X., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.009 · Cited by 63
Self-citationInsular resting state functional connectivity is associated with gut microbiota diversity
Curtis, K. N., Stewart, C. J., Robinson, M. E., Molfese, D. L., Gosnell, S. N., Kosten, T. R., Petrosino, J. F., Garza, R. D. L., & Salas, R. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14305 · Cited by 62
Dutta, A., McKie, S., Downey, D., Thomas, E., Juhász, G., Arnone, D., Elliott, R., Williams, S. R., Deakin, J. F. W., & Anderson, I. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0447-0 · Cited by 61
Chen, X., van Gerven, J., Cohen, A. F., & Jacobs, G. E. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0185-5 · Cited by 60
Zhang, J., Gao, T., Wang, Y., Wang, J., Guan, W., Wang, Y., Wang, C., Liu, J., & Jiang, B. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz032 · Cited by 58
Regulation of Circadian Genes by the MAPK Pathway: Implications for Rapid Antidepressant Action
Wang, X., Yuan, K., Zhang, W., Li, S., Gao, G. F., & Lü, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00358-9 · Cited by 55
Ma, X., Xiang, Y., Cai, Z., Li, S., Xiang, Y., Guo, H.-L., Hou, Y., Li, Z.-B., Li, Z., Tao, Y., et al. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.010 · Cited by 52
Self-citationMeyer, B. M., Rabl, U., Huemer, J., Bartova, L., Kalcher, K., Provenzano, J., Brandner, C., Sezen, P., Kasper, S., Schatzberg, A. F., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0395-8 · Cited by 52
Chiou, Y., & Huang, T. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw096 · Cited by 50
BDNF pro-peptide: physiological mechanisms and implications for depression
Kojima, M., Matsui, K., & Mizui, T. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03034-6 · Cited by 49
Zhang, L., Shi, L., Liu, H., Meng, F., Liu, Y., Wu, H., Du, X., & Zhou, J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000411 · Cited by 48
Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
Kolata, S., Nakao, K., Jeevakumar, V., Farmer-Alroth, E. L., Fujita, Y., Bartley, A. F., Jiang, S. Z., Rompala, G. R., Sorge, R. E., Jimenez, D. V., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.296 · Cited by 48
The antidepressant effect of light therapy from retinal projections.
Li, X., & Li, X. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0210-1 · Cited by 47 · cited 1×
“treatments for depression have emerged, such as transcranial direct current stimulation (tDCS) [155], transcranial alternating current stimulation (tACS)[156], vagal nerve stimulation [157], deep brain stimulation [158] , and light therapy [159], but some of them are still experimental to some extent and have not been…”
BackgroundWhite Matter Abnormalities in Major Depression Biotypes Identified by Diffusion Tensor Imaging
Liang, S., Wang, Q., Kong, X., Deng, W., Yang, X., Li, X., Zhang, Z., Zhang, J., Zhang, C., Li, X., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00381-w · Cited by 44
Lv, X., Si, T., Wang, G., Wang, H., Liu, Q., Hu, C., Wang, J., Su, Y., Huang, Y., Jiang, H., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0953-z · Cited by 41
Li, Z., Wang, Z., Zhang, C., Chen, J., Su, Y., Huang, J., Yi, Z., Yuan, C., Hong, W., Wang, Y., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.015 · Cited by 41
Self-citationSchwabe, I., Milaneschi, Y., Gerring, Z. F., Sullivan, P. F., Schulte, E. C., Suppli, N. P., Thorp, J. G., Derks, E. M., & Middeldorp, C. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719002502 · Cited by 41
Aubry, J.-M. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.09.003 · Cited by 40
Owashi, T., Otsubo, T., Oshima, A., Nakagome, K., Higuchi, T., & Kamijima, K. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.10.011 · Cited by 34
Ho, T. C., Gutman, B. A., Pozzi, E., Grabe, H. J., Hosten, N., Wittfeld, K., Völzke, H., Baune, B. T., Dannlowski, U., Förster, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/534370 · Cited by 30
Zhang, Y., Rao, W., Cui, L., Li, J., Li, L., Ng, C. H., Ungvari, G. S., Li, K., & Xiang, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.049 · Cited by 27
Hou, Z., Gong, L., Zhi, M., Yin, Y., Zhang, Y., Xie, C., & Yuan, Y. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9773-0 · Cited by 22
Cortisol trajectory, melancholia, and response to electroconvulsive therapy
Mickey, B. J., Ginsburg, Y., Sitzmann, A. F., Grayhack, C., Sen, S., Kirschbaum, C., Maixner, D. F., & Abelson, J. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.007 · Cited by 20
Neuroimmune Advance in Depressive Disorder
Zhao, G., & Liu, X. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9271-0_4 · Cited by 20
Crescenzo, F. D., Ciliberto, M., Menghini, D., Treglia, G., Ebmeier, K. P., & Janiri, L. (2016) · Aging & Mental Health · doi:10.1080/13607863.2016.1247413 · Cited by 19
Miskowiak, K. W., Macoveanu, J., Jørgensen, M. B., Støttrup, M. M., Ott, C. V., Jensen, H. M., Jørgensen, A., Harmer, J., Paulson, O. B., Kessing, L. V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx091 · Cited by 9
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
The molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
Department of Mental Rehabilitation, R. H. O. H. P., Liu, L., Wang, K., Department of Clinical psychiatry, R. H. O. H. P., Xu, D., Department of Mental Rehabilitation, R. H. O. H. P., Wang, Y., Department of Clinical psychiatry, R. H. O. H. P., Xu, X., Department of Clinical psychiatry, R. H. O. H. P., et al. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.241731 · Cited by 5
Inozemtseva, L. S., Yatsenko, K. A., Glazova, N. Y., Kamensky, A. A., Myasoedov, N. F., Levitskaya, N. G., Grivennikov, I. A., & Dolotov, O. V. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177068 · Cited by 5
Metadata
- Authors
- Li, Z., Ruan, M., Chen, J., & Fang, Y.
- Venue
- Neuroscience Bulletin
- Published
- 2021-02-13
- Volume
- 37
- Issue
- 6
- Pages
- 863-880
- ISSN
- 1995-8218 (ISSN-L)
- 1673-7067
- OpenAlex
- W3130188116
- Cited by
- 326
- References
- 165
- FWCI
- 26.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.